APA (7th ed.) Citation

VG, G., KF, R., HB, P., AK, G., S, G., & D, K. (2025). The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model. BMC cancer, 25(1), 233. https://doi.org/10.1186/s12885-025-13640-z

Chicago Style (17th ed.) Citation

VG, Gupta, Roby KF, Pathak HB, Godwin AK, Gunewardena S, and Khabele D. "The Tie2 Antagonist Rebastinib Reduces Ovarian Cancer Growth in a Syngeneic Murine Model." BMC Cancer 25, no. 1 (2025): 233. https://doi.org/10.1186/s12885-025-13640-z.

MLA (9th ed.) Citation

VG, Gupta, et al. "The Tie2 Antagonist Rebastinib Reduces Ovarian Cancer Growth in a Syngeneic Murine Model." BMC Cancer, vol. 25, no. 1, 2025, p. 233, https://doi.org/10.1186/s12885-025-13640-z.